- call +1-201-465-4211
- email sales@mrinsights.biz
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
Scope of the Report:
The global average gross margin of BCG Vaccine is in an decreasing trend, from 71.59% in 2012 to 69.46% in 2017. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The type of BCG Vaccine includes Immune BCG and Therapy BCG. The proportion of Therapy BCG in 2016 is about 92.73%.
BCG Vaccine is widely used in Hospitals and Clinics. The most proportion of BCG Vaccine is sold in Hospitals and the market share in 2016 is about 74.14%, and the Hospitals have upstream trend.
North America is the largest supplier of BCG Vaccine, with a production market share nearly 32.58% in 2016. Europe is the second largest supplier of BCG Vaccine Media, enjoying production market share nearly 29.74% in 2016.
North America region is the largest consumption of BCG Vaccine, with a sales revenue market share nearly 36.40% in 2016. Europe is the second largest consumer of BCG Vaccine, enjoying sales revenue market share about 32.43% in 2016.
Market competition is not intense. Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL are the leaders of the industry, and they have been formed in the monopoly position in the industry.
The worldwide market for BCG Vaccine is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 410 million US$ in 2024, from 300 million US$ in 2019, according to a new study.
This report focuses on the BCG Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immune BCG
Therapy BCG
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe BCG Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of BCG Vaccine, with price, sales, revenue and global market share of BCG Vaccine in 2017 and 2018.
Chapter 3, the BCG Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, BCG Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe BCG Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 BCG Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Immune BCG
1.2.2 Therapy BCG
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 BCG Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck BCG Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi Pasteur
2.2.1 Business Overview
2.2.2 BCG Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Pasteur BCG Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Japan BCG Lab
2.3.1 Business Overview
2.3.2 BCG Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Japan BCG Lab BCG Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 China National Biotec
2.4.1 Business Overview
2.4.2 BCG Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 China National Biotec BCG Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Serum Institute of India
2.5.1 Business Overview
2.5.2 BCG Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Serum Institute of India BCG Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Intervax
2.6.1 Business Overview
2.6.2 BCG Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Intervax BCG Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 GSBPL
2.7.1 Business Overview
2.7.2 BCG Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GSBPL BCG Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global BCG Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global BCG Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global BCG Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 BCG Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 BCG Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global BCG Vaccine Market Analysis by Regions
4.1 Global BCG Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global BCG Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global BCG Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America BCG Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe BCG Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific BCG Vaccine Sales and Growth Rate (2014-2019)
4.5 South America BCG Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa BCG Vaccine Sales and Growth Rate (2014-2019)
5 North America BCG Vaccine by Country
5.1 North America BCG Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America BCG Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America BCG Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States BCG Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada BCG Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico BCG Vaccine Sales and Growth Rate (2014-2019)
6 Europe BCG Vaccine by Country
6.1 Europe BCG Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe BCG Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe BCG Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany BCG Vaccine Sales and Growth Rate (2014-2019)
6.3 UK BCG Vaccine Sales and Growth Rate (2014-2019)
6.4 France BCG Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia BCG Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy BCG Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific BCG Vaccine by Country
7.1 Asia-Pacific BCG Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific BCG Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific BCG Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China BCG Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan BCG Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea BCG Vaccine Sales and Growth Rate (2014-2019)
7.5 India BCG Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia BCG Vaccine Sales and Growth Rate (2014-2019)
8 South America BCG Vaccine by Country
8.1 South America BCG Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America BCG Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America BCG Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil BCG Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina BCG Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia BCG Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa BCG Vaccine by Countries
9.1 Middle East and Africa BCG Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa BCG Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa BCG Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia BCG Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey BCG Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt BCG Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria BCG Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa BCG Vaccine Sales and Growth Rate (2014-2019)
10 Global BCG Vaccine Market Segment by Type
10.1 Global BCG Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global BCG Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global BCG Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Immune BCG Sales Growth and Price
10.2.1 Global Immune BCG Sales Growth (2014-2019)
10.2.2 Global Immune BCG Price (2014-2019)
10.3 Therapy BCG Sales Growth and Price
10.3.1 Global Therapy BCG Sales Growth (2014-2019)
10.3.2 Global Therapy BCG Price (2014-2019)
11 Global BCG Vaccine Market Segment by Application
11.1 Global BCG Vaccine Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 BCG Vaccine Market Forecast (2019-2024)
12.1 Global BCG Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 BCG Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America BCG Vaccine Market Forecast (2019-2024)
12.2.2 Europe BCG Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific BCG Vaccine Market Forecast (2019-2024)
12.2.4 South America BCG Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa BCG Vaccine Market Forecast (2019-2024)
12.3 BCG Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global BCG Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global BCG Vaccine Market Share Forecast by Type (2019-2024)
12.4 BCG Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global BCG Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global BCG Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure BCG Vaccine Picture
Table Product Specifications of BCG Vaccine
Figure Global Sales Market Share of BCG Vaccine by Types in 2018
Table BCG Vaccine Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
